Eli Lilly Gets Fast Track Status For Its Tirzepatide To Treat Obesity

Eli Lilly and Company (LLY) on Thursday said it received Fast Track designation for tirzepatide for the treatment of obesity or or overweight with weight-related comorbidities.

Tirzepatide is in Phase 3 study in adults with obesity, or overweight with weight-related comorbidity.

Tirzepatide was approved as Mounjaro by the FDA in May this year, to improve glycemic control in adults with 2 diabetes mellitus, as an adjunct to diet and exercise.

Lilly said it plans to initiate a rolling submission of a new drug application for tirzepatide in adults with obesity or overweight this year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Weis Markets, Inc., a Mid Atlantic food retailer, has recalled 108 containers of Weis Quality Sea Salt Caramel Ripple Ice Cream citing possible presence of undeclared soy and coconut allergens, the U.S. Food and Drug Administration said. The recalled product comes in 48oz containers that says Weis Quality Sea Salt Caramel Ripple Ice Cream, while the lid says Weis Quality Caramel Caribou Ice Cream Amazon.com Inc. plans to spend more than $1 billion annually to produce movies that will get a theatrical release, Bloomberg reported, citing people familiar with the matter. The online retailer giant, which acquired movie maker MGM Studios earlier this year for $8.45 billion, is likely to produce between 12 and 15 movies each year for movie theaters. New York-based Bentex Group has recalled various children's clothing sets due to violation of the federal lead paint and lead content ban, as well as lead poisoning risk, the U.S. Consumer Product Safety Commission said. The recall involves about 87,000 units of Bentex children's clothing sets in nine different Disney themed styles.
Follow RTT